Trial intelligence / Profile preview

Intranasal tranexamic acid vs placebo for spontaneous epistaxis in the Emergency Department

2016-001530-10Phase 3Completed

Sponsor
Royal Devon University Healthcare NHS Foundation Trust
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in epistaxis comparing Intranasal tranexamic acid with Placebo intranasal treatment (2 arms). Primary endpoint: Use of anterior nasal packing during ED attendance. Started Oct 2018; status: completed.

02

Drugs

tranexamic acid
03

Conditions

epistaxis

Beyond the preview

Go deeper on 2016-001530-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001530-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call